Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
🏛 National Institutes of Health (HHS-NIH11)
✓ Free, no account · Source: Grants.gov · Last verified Oct 18, 2026
Can you apply?
This grant is for researchers and research institutions seeking to advance fundamental understanding of genetic architecture underlying complex human traits. Eligible applicants typically include academic research institutions, medical centers, nonprofit research organizations, and certain government laboratories. Applicants must have faculty or research status at eligible institutions and access to appropriate research facilities. The program supports development of novel theoretical frameworks and statistical/computational methods for dissecting genetic contributions to complex traits like disease susceptibility, quantitative traits, and polygenic influences. Research must not involve clinical trials. Geographic scope is U.S.-based institutions, though international collaborations may be permitted as secondary participants. Activities include method development, theoretical innovation, validation studies, and computational tool creation—but exclude direct clinical testing of interventions or patient recruitment for experimental protocols.
Not the right fit? Find grants for your organization in 5 questions →
Program description
The goal of this NOFO is to support applications for novel theory and methods development that enable better understanding of how genetic and non-genetic factors contribute to complex trait variation across individuals, families, and populations. Approaches should be interdisciplinary drawing from the natural and social sciences, account for interdependencies across scales of biological, social, and ecological organization, and make extensive use of theory, modeling, and validation with available large-scale datasets.
Who can apply
Eligible applicants
How to apply
Application links
Required documents
- NIH Form SF-424 (R&R) and SF-424 (R&R) Supp Cover Sheet
- Project Narrative (Specific Aims, Research Strategy, and other required sections; typically 15 pages)
- Biosketches for key personnel (current NIH format, 5 pages each)
- Budget and Budget Justification (Form PHS 398)
- Institutional support letters and cost-sharing documentation (if applicable)
- IRB/IACUC approvals or exemption documentation (if human or animal subjects are involved)
- Letters of collaboration from partner institutions
- Data management and sharing plan
- Resource availability documentation (computing facilities, datasets, etc.)
Program contact
- 👤 National Institutes of Health
- 📧 grantsinfo@nih.gov
- 📞 301-402-2541
Funding track record
Recent awards under CFDA 93.399 from the last 3 years — real organizations that won funding through this same program.
Top 10 Largest Recent Awards
-
$31,699,712
-
$23,221,095
-
$22,629,848
-
$20,624,330
-
$20,449,106
-
$20,018,954
-
$19,957,085
-
$17,864,446
-
$16,730,455
-
$16,126,587
Top States by Funding
- NY 7 awards $64.5M
- SC 3 awards $52.1M
- IL 4 awards $48.9M
- WI 4 awards $48.2M
- PA 4 awards $41.0M
Source: USAspending.gov — federal spending transparency. Data covers last 3 years.
FAQ
Who is eligible to apply for this NIH R01 grant?
Researchers at domestic for-profit and nonprofit organizations, universities, and government agencies with appropriate research infrastructure are eligible. Applicants must hold a research or faculty position and have the ability to conduct independent research. International applicants must be employed by a U.S. institution.
What is the application deadline and when does the submission window open?
The fixed deadline is November 5, 2026. The submission window typically opens 30 days prior to the deadline, around October 6, 2026. Check NIH Grants.gov for exact submission opening dates.
What types of research activities are supported by this grant?
The program supports development of novel genetic theory, statistical and computational methods, and analytical approaches for understanding complex trait architecture. Clinical trials, drug testing, and direct human subject interventions are not allowed under this mechanism.
How competitive is this R01 mechanism?
NIH R01 grants are highly competitive, with success rates typically ranging from 18-20% nationwide. Strong preliminary data, novel methodology, and experienced research teams significantly increase competitiveness.
What is the typical funding range?
R01 awards typically support projects with total costs ranging from $200,000–$400,000+ annually, depending on research scope and institutional geographic adjustment. Project periods are usually 3-5 years. Consult current NIH funding announcements for exact budget constraints.
💡 Tips for applicants
- Establish preliminary data demonstrating feasibility of your novel theoretical or methodological approach before applying; NIH reviewers heavily weight proof-of-concept evidence for methods development grants.
- Clearly delineate how your methods advance beyond existing tools and approaches; articulate the specific scientific gap your innovation addresses in complex trait genetics.
- Build a realistic timeline showing both method development and validation phases; demonstrate that your computational/statistical innovations are testable and will be made available to the broader research community.
- Engage biostatisticians and bioinformaticians early in proposal development; this grant type requires rigorous technical rigor and clear documentation of algorithm development and validation.
- Consider including a data-sharing and resource-dissemination plan; NIH increasingly prioritizes grants that will produce shareable tools, software, or datasets accessible to other researchers.
⚠️ Common mistakes
Applications often underestimate the need for strong preliminary data demonstrating that the proposed methods actually work in practice. Reviewers expect evidence that your theoretical framework is not purely conceptual but grounded in feasibility testing. Additionally, many applications fail to clearly distinguish their methodological innovation from existing computational tools already available to the field, or they lack a sufficiently rigorous validation strategy across diverse datasets or trait types.
Similar grants
- OPEN Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Screening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed) — National Institutes of Health
- OPEN Development of Models, New Approach Methodologies, and Biological Materials for Studying Human Health and Diseases (R21 Clinical Trial Not Allowed) — National Institutes of Health